Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy.
about
Different Subsets of T Cells, Memory, Effector Functions, and CAR-T ImmunotherapyChanging perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agentsAutophagy is a signature of a signaling network that maintains hematopoietic stem cellsSingle-cell entropy for accurate estimation of differentiation potency from a cell's transcriptomeMitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma.IL-15 signaling promotes adoptive effector T-cell survival and memory formation in irradiation-induced lymphopeniaEnergy metabolism in the acquisition and maintenance of stemness.Oxidative status predicts quality in human mesenchymal stem cells.Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control.Mitochondrial heterogeneity, metabolic scaling and cell death.Eat, breathe, ROS: controlling stem cell fate through metabolism.Hypoxia and antitumor CD8+ T cells: An incompatible alliance?Filling the Tank: Keeping Antitumor T Cells Metabolically Fit for the Long Haul.T memory stem cells in health and disease.The Principles of Engineering Immune Cells to Treat Cancer.Fine tuning of immunometabolism for the treatment of rheumatic diseases.Mitochondria are the powerhouses of immunity.Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don't Forget the FuelBiochemical Underpinnings of Immune Cell Metabolic Phenotypes.Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy.The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction.Metabolic orchestration of T lineage differentiation and function.Emerging concepts of T cell metabolism as a target of immunotherapy.Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy.Metastasectomy for Tumor-Infiltrating Lymphocytes: An Emerging Operative Indication in Surgical Oncology.Uncoupling Protein 2 Inhibits Myointimal Hyperplasia in Preclinical Animal Models of Vascular Injury.Mitochondrial Priming by CD28.B1a B cells require autophagy for metabolic homeostasis and self-renewal.Innate and Adaptive Immune Cell Metabolism in Tumor Microenvironment.Dendritic cell vaccine induces antigen-specific CD8+ T cells that are metabolically distinct from those of peptide vaccine and is well-combined with PD-1 checkpoint blockade.Prime pick: Researchers get selective about T cells for cancer therapy.Use the Protonmotive Force: Mitochondrial Uncoupling and Reactive Oxygen Species.IL-21 modulates memory and exhaustion phenotype of T-cells in a fatty acid oxidation-dependent manner.Targeting T Cell Metabolism for Improvement of Cancer ImmunotherapyCrosstalks between mTORC1 and mTORC2 variagate cytokine signaling to control NK maturation and effector function
P2860
Q26752955-573F0135-A602-4449-BA3F-F97DA0BB4EA8Q28073524-A3D61664-6CA3-4E19-9BDB-4A750735392EQ33653088-CCD6DD07-15EA-4C46-8E9C-C520E1872AEFQ33771221-FE9BA241-D7DA-4742-8C3E-B1710AE43BB1Q33798098-278D6EF9-D190-401C-8AA4-E211201B176FQ36875832-9719F622-9562-49BE-8FDD-15A47D7F2FEBQ36998506-391D8C5E-2AEB-4746-9B49-E66521B0614BQ37566969-8570A5F9-8D01-4A41-8E57-738CD09F3B3EQ37688373-6405B066-F927-46C2-B2D6-C861A7E7F167Q38673293-8C5151BE-ECEE-45A1-8F46-35F2AF708B9DQ38730864-29325EB6-F759-42E8-9DC4-58C982A0C3C9Q38998450-A80001C3-ACF8-41B8-B4F2-13D062225A42Q39026430-C62ED2F5-3592-4B28-98D9-16B2C571884FQ39070577-51F7D1FB-506F-4C7E-927D-7EBD84D33A85Q39130457-A96F6754-19DB-4C7F-B25A-84871F515770Q39223057-A852D107-FD94-4700-A3FD-293E737C4DB1Q39248031-5DBEA899-314F-444B-AC00-42D84E5E15FEQ39249589-CD28D3C9-A249-4E52-A1AB-89CCC00D14FEQ39313207-E0498560-B84D-462C-B54D-CB4BBD726B6AQ39418546-1A0FF427-C3EE-42C8-A3D7-2992C83F5A0AQ39518049-1545B9F5-6167-431E-8C87-BB6972596010Q40049632-F11784A5-DD72-4682-A9C2-3ED2B4AE087FQ40745622-9BB2B048-3103-4514-98ED-8B92DD05C4ABQ45875529-AAA9233E-446D-4005-8DB4-F1EC3F1FAEF5Q46056233-F147821D-EA62-40EE-8CB1-C2103D7FE6A8Q47135942-8DCA6339-7B99-4BCE-B9AF-4D6BB3D93167Q47770635-DB9043BC-48F3-4683-9B8C-A208FF5FE3CDQ48257333-CA3F2952-FB56-4EF8-BB77-1B15F517BD08Q50217779-F0636D60-02F9-4F17-9691-B4AC4CE5730AQ50535288-C465FBDD-FEE8-4B03-B58E-3A05FCAE33BFQ51343968-3BEE56F0-D81B-403B-B6FC-C7AD5F4C31EBQ52329316-A39051FF-CDEA-450D-8B35-EA3F8E1C4853Q52641602-F190E953-15A3-45C3-AB0E-04C4D2A2F8ACQ58801754-3FB48F55-93F5-4FF5-8C56-7EBF248BB88DQ59125254-BB9330D0-F844-41E2-94F3-A0DDD63AEDF5
P2860
Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Mitochondrial Membrane Potenti ...... Stemness for Cellular Therapy.
@ast
Mitochondrial Membrane Potenti ...... Stemness for Cellular Therapy.
@en
type
label
Mitochondrial Membrane Potenti ...... Stemness for Cellular Therapy.
@ast
Mitochondrial Membrane Potenti ...... Stemness for Cellular Therapy.
@en
prefLabel
Mitochondrial Membrane Potenti ...... Stemness for Cellular Therapy.
@ast
Mitochondrial Membrane Potenti ...... Stemness for Cellular Therapy.
@en
P2093
P2860
P50
P1433
P1476
Mitochondrial Membrane Potenti ...... Stemness for Cellular Therapy
@en
P2093
David S Schrump
Francesco M Marincola
Greg D Whitehill
Joseph G Crompton
Keyvan Keyvanfar
Luca Gattinoni
Madhusudhanan Sukumar
Mahadev Rao
P2860
P356
10.1016/J.CMET.2015.11.002
P50
P577
2015-12-08T00:00:00Z